• About Us
  • Who Are We
  • Work With Us
Friday, June 2, 2023
No Result
View All Result
NEWSLETTER
The Globe Post
39 °f
New York
44 ° Fri
46 ° Sat
40 ° Sun
41 ° Mon
No Result
View All Result
The Globe Post
No Result
View All Result
Home Featured

The Sputnik V Vaccine: A Scientific and Political Win for Russia

Staff Writer by Staff Writer
02/03/21
in Featured, World
A health worker holds a bottle of Russia's Sputnik V vaccine.

A health worker holds a bottle of Russia's Sputnik V vaccine. Photo: AFP

Share on FacebookShare on Twitter

First greeted with scepticism, experts have since been convinced of the effectiveness of the Russian coronavirus vaccine, Sputnik V, with positive results published in The Lancet medical journal on Tuesday. 

The development represents a scientific and political victory for Vladimir Putin‘s Russia. 

Putin at the forefront

From the first weeks of the pandemic, the Russian president ordered the scientific, political and military apparatus of the country to work in overdrive to develop the world’s first Covid vaccine — even if that meant taking shortcuts. 

Last spring, Alexander Gintsburg, the director of the state-run Gamaleya research center that developed Sputnik V, boasted of having personally injected himself with an experimental version of the jab.

A few months later, in mid-August, Putin announced the approval of the world’s first coronavirus vaccine. 

With the shot at that point having only been tested by a few dozen volunteers, the proclamation was greeted with scepticism abroad.

The vaccine nonetheless soon became available to Russia’s elite, including one of Putin’s daughters, even before the beginning of Phase III clinical trials involving tens of thousands of volunteers. 

Russia made the vaccine available to the wider public in December, when Europe and the United States were just deploying the first doses of the vaccines made by their pharmaceutical companies.

Global ambitions

For the Kremlin, the homemade vaccine — first vilified by the West — demonstrates Russia’s excellence, with Putin having called Sputnik V “the best vaccine in the world”.

The choice of name for the jab is highly symbolic. A tribute to the world’s first satellite, launched by the Soviet Union in 1957, Sputnik V recalls a scientific feat for Russia and a historic setback for its rival the United States. 

The success of the vaccine restores Russian research capabilities to the world’s top echelons, after the sector had been decimated by crises and corruption in the wake of the USSR’s collapse in 1991.

Sputnik V has been approved in more than 15 countries, including ex-Soviet nations like Belarus and Armenia, allies like Venezuela and Iran, but also Argentina, Algeria, Tunisia and Pakistan. 

Sputnik V in Europe?

Last month the Russian Direct Investment Fund (RDIF), which helped finance Sputnik V, announced that it had applied for registration of the vaccine in the European Union.   

But the Russian vaccine has been treated with suspicion due to a lack of publicly available scientific data. 

Denouncing European delays, Viktor Orban‘s Hungary sidestepped the European Medicines Agency (EMA) and registered the vaccine on its own.

For her part, German Chancellor Angela Merkel has offered Putin the possibility of “joint production”.

Production capacity?

Russia says it has received pre-orders of more than a billion doses of Sputnik V, but it is unable to meet that level of demand. 

The quantities of doses that have been delivered abroad have mainly been symbolic, like the 20,000 exported to Bolivia. 

In some cases the figures were not revealed, while Argentina experienced a shipment delay last month.

No official source has made clear how many doses have been produced or deployed, though authorities in mid-January said that 1.5 million people had been inoculated with Sputnik V around the world.

Rather than exporting Sputnik V in bulk, Moscow hopes to develop production partnerships with local factories.

Brazil, India, Kazakhstan and South Korea are currently producing the jab, though not all them have made it available to the public yet. 

Other Russian vaccines

At least three more Russian coronavirus vaccines are expected to be rolled out in the coming weeks. 

Sputnik V — a two-dose vaccine using adapted strains of the adenovirus, a virus that causes the common cold — is set to be produced as “Sputnik Light”, a less effective single-dose version.

Mass production of the EpiVacCorona vaccine, developed by the Siberian Vektor laboratory, is set to launch this month. 

The Russian government has said that a third vaccine named CoviVac is expected to be approved this month too.

And there may even be a fourth, with the Anglo-Swedish firm AstraZeneca and the developers of Sputnik V having said they are working to combine their respective vaccines.

ShareTweet
Staff Writer

Staff Writer

AFP with The Globe Post

Related Posts

Military hardware rolls through Dvortsovaya Square during a Victory Day military parade in central Saint Petersburg
National

Pressing Russia, US Shares Nuclear Warhead Data Under Treaty

by Staff Writer
May 16, 2023
Ukrainian refugees
World

Russia Says Ready to Return Ukraine Children if Parents Request

by Staff Writer with AFP
April 5, 2023
Russian Prime Minister Vladimir Putin
World

Russia Fighting for Its ‘Historical Lands:’ Putin

by Staff Writer
February 23, 2023
Soledar lies 15 kilometres (nine miles) from the city of Bakhmut, which Russia has been trying to seize for months
World

Fate of Ukraine’s Soledar Unclear as Wagner Claims Control

by Staff Writer
January 11, 2023
Russian passports
World

EU Won’t Recognize Russian Passports From Occupied Ukraine

by Staff Writer
November 10, 2022
Russia Today
World

Russian TV Host Apologizes for Calls to Burn Ukrainian Children

by Staff Writer
October 24, 2022
Next Post
US State Department spokesman Ned Price speaking at a press conference.

US 'Disappointed' as UN Court Takes Up Iran Sanctions

Half a million Americans died in overdoses from both prescription and illegal opioids between 1999 and 2018.

McKinsey Reaches $573M Settlement Over Opioid Crisis

Recommended

A man holds US, Taiwan flags

US and Taiwan Ink Trade Deal as China Issues Warning

June 2, 2023
Migrants waiting at the Turkish border.

Beyond Numbers: Confronting Europe’s Broken Border System

May 30, 2023
A noose is seen on makeshift gallows as supporters of US President Donald Trump gather on the West side of the US Capitol in Washington DC on January 6, 2021

Militia Leader Gets 18 Years in Prison Over US Capitol Attack

May 26, 2023
Customers queue to enter a re-opened Zara clothes shop

EU Targets Fast Fashion in Push for Durable Goods

May 23, 2023
A billboard showing the debt limit is seen in Washington, D.C.

US Republicans Upbeat on Prospects for Debt Deal

May 19, 2023
Military hardware rolls through Dvortsovaya Square during a Victory Day military parade in central Saint Petersburg

Pressing Russia, US Shares Nuclear Warhead Data Under Treaty

May 16, 2023

Opinion

Migrants waiting at the Turkish border.

Beyond Numbers: Confronting Europe’s Broken Border System

May 30, 2023
A man holding a gun

The NRA’s Continuing Agenda of Fear

May 12, 2023
US Supreme Court Justice Clarence Thomas

A Supreme Folly 

April 24, 2023
Transgender Army veteran Tanya Walker speaks to protesters in Times Square near a military recruitment centre

Tennessee Is A Drag on the First Amendment

March 26, 2023
Chinese President Xi Jinping

China’s Path to Economic Dominance

March 15, 2023
An earthquake survivor reacts as rescuers look for victims and other survivors in Hatay, a Turkish province where hundreds of buildings were destroyed by the earthquake

Heed the Call of Our Broken World

March 1, 2023
Facebook Twitter

Newsletter

Do you like our reporting?
SUBSCRIBE

About Us

The Globe Post

The Globe Post is part of Globe Post Media, a U.S. digital news organization that is publishing the world's best targeted news sites.

submit oped

© 2018 The Globe Post

No Result
View All Result
  • National
  • World
  • Business
  • Interviews
  • Lifestyle
  • Democracy at Risk
    • Media Freedom
  • Opinion
    • Editorials
    • Columns
    • Book Reviews
    • Stage
  • Submit Op-ed

© 2018 The Globe Post